Pioneering transformational drug discovery and development in the areas of cancer and fibrosis
RXC004 – Clinical Phase 1 study ongoing
Pioneering transformational drug discovery and development in the areas of cancer and fibrosis
Lead fibrosis programme – Pan-ROCK inhibitor for fibrosis related to IBD
GBX 11.00GBp
LON : REDX 19/06/2018 12:57PM

Drug discovery and development business creating high value cancer and fibrosis therapeutics

More about Redx Pharma